MedTrace Logo

A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine

NCT03133325 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-08-25

No results posted yet for this study

Summary

This is a study to assess the safety of GP0045 compared to Restylane Lyft Lidocaine.

There is a 12-week follow-up period. AEs will be recorded throughout the study.

Conditions

  • Safety

Interventions

DEVICE

GP0045

Hyaluronic acid gel

DEVICE

Restylane Lyft Lidocaine

Hyaluronic acid gel

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-19
Primary Completion
2017-07-13
Completion
2017-07-13

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03133325 on ClinicalTrials.gov